Cited by 3Probiotics and Fermented FoodsInfant Nutrition and HealthEscherichia coli research studies

Protective Effects of Bifidobacterium bifidum Strains with IgA-Potentiating Activity Against ETEC Infection in Weanling Mice

Zhao, Maozhen, Ma, Qiyu, Meng, Yang, Hung, Weilian, Zhao, Wen, Zeng, Zhaozhong, Yi, Huaxi, Zhang, Lanwei +1 more·2026·Probiotics and Antimicrobial Proteins

Abstract

Enterotoxigenic Escherichia coli (ETEC) remains a leading cause of diarrheal morbidity and mortality in infants and young children worldwide. Weanling infants are particularly vulnerable due to the loss of maternal immunoglobulin A (IgA) protection and insufficient endogenous IgA production. Bifidobacterium bifidum FL228.1 and FL276.1 have been identified as strains capable of enhancing intestinal IgA levels in healthy weanling mice; however, their protective efficacy under pathogenic challenge was unknown. In this study, these strains were evaluated in an ETEC-infected weanling mouse model. Oral supplementation with FL228.1 or FL276.1 was associated with elevated small intestinal IgA levels (29.30% and 19.27%, respectively) and increased numbers of IgA⁺ cells (1.85-fold and 1.67-fold) compared with uninfected controls. Notably, both interventions markedly reduced ETEC load, alleviated growth retardation, mitigated intestinal tissue injury, and reduced systemic inflammatory responses. In addition, the probiotics counteracted ETEC-induced gut dysbiosis by restricting the overgrowth of pathogenic taxa (e.g., Escherichia-Shigella) and preserving beneficial populations (e.g., norank_f__Muribaculaceae). These results indicate that FL228.1 and FL276.1 confer protection against ETEC infection in weanling mice, an effect associated with their IgA-potentiating activity alongside modulation of inflammation, barrier function, and gut microbiota composition.

Integrity signals

Registry

Crossref · 10.1007/s12602-025-10782-1

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • B. bifidum is characteristic of the bifidobacterial communities residing in the infant gut and contributes to early microbial colonization, alongside B. breve.

    “B. bifidum is characteristic of the bifidobacterial communities residing in the infant gut and contributes to early microbial colonization, alongside Bifidobacterium breve [6-10] .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, M., Ma, Q., Meng, Y., Hung, W., Zhao, W., Zeng, Z., Yi, H., Zhang, L., & Zhang, Z.
Affiliations
Ocean University of China (CN)
Corresponding author
  • Zhang, Lanwei
  • Zhang, Zhe
Venue
Probiotics and Antimicrobial Proteins
Published
2025-10-06
Volume
18
Issue
3
Pages
4598-4609
ISSN
  • 1867-1306 (ISSN-L)
  • 1867-1314
OpenAlex
W4414848754
Cited by
3
References
41
Citations by year
2026: 3
FWCI
1.41
Type
journal article
Language
en
Open access
closed
Locations
  • Probiotics and Antimicrobial Proteins (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • the National Key Research and Development Program of China (2024YFE0111400)
  • the Natural Science Foundation of China (32402044)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Escherichia coli research studies
Keywords
Bifidobacterium bifidum, enterotoxigenic Escherichia coli, probiotics, weanling mice, infant diarrhea, intestinal IgA, gut dysbiosis, intestinal inflammation, intestinal barrier function, gut microbiota, Escherichia-Shigella, Muribaculaceae
MeSH terms
Gastrointestinal Microbiome, Bifidobacterium bifidum, Animals, Escherichia coli Infections, Female, Humans, Immunoglobulin A, Male, Weaning, Probiotics, Mice, Enterotoxigenic Escherichia coli

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review